SCHEMBL23609784

SCHEMBL23609784

CCNc1cc(Nc2ccccc2)ccc1-c1c(C)cccc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.44
ALDH1A1 P00352 6/20 0.42
MAPT P10636 5/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
AR P10275 1/20 0.42
LMNA P02545 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GFER P55789 1/20 0.40
HSD17B10 Q99714 4/20 0.40
SRC P12931 4/20 0.40
MAPK1 P28482 3/20 0.40
HPGD P15428 2/20 0.40
APP P05067 1/20 0.39
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22995644 0.79 NPSR1 (0.47) NPSR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL23609005 0.78 CSNK2A2 (0.36) NPSR1ALDH1A1MAPTMEN1KMT2A
Diphenylamine SCHEMBL5223111 0.75 MAPT (0.47) NPSR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL23609704 0.75 LTA4H (0.38) NPSR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL13308526 0.70 HPGD (0.58) NPSR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL4639004 0.70 HPGD (0.58) NPSR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL29416259 0.70 HPGD (0.58) NPSR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL23609098 0.70 ALDH1A1 (0.36) NPSR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL1851950 0.70 ALDH1A1 (0.62) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL23567608 0.70 HPGD (0.52) NPSR1ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021133689-A2 LIPOXYGENASE INHIBITORS SRI INTERNATIONAL (US) 2021-07-01 WO disclosed